Leukemia
Acute myeloid leukemia in a patient with ataxia-telangiectasia: a case report and review of the literature TO THE EDITOR Ataxia telangiectasia (AT) is an autosomal recessive disorder characterized by cerebral degeneration, immunodeficiency, cancer predisposition, radiation sensitivity and cell cycle abnormalities. This unique phenotype is due to the mutated gene ATM that is located on chromosome 11q22-23 1 and the carriers' frequency of AT locus mutations is about 1.5-3% of the general population. 2 Compared with non-carriers, the heterozygotes for ATM mutations died 7 to 8 years earlier, mainly due to cancer and heart strokes, 3 while homozygotes have an increased risk for developing malignancies, especially of lymphoid origin, 4 like acute lymphoblastic leukemia (ALL), lymphomas or prolymphocytic leukemia (PLL). Even if B cell tumors are often in AT patients, there is a four-to five-fold increased frequency of T cell tumors compared with that of B cell origin in these patients. 5 Abnormal expression of ATM protein is a frequent finding in patients with B cell chronic lymphocytic leukemia (B-CLL) and approximately 14% of these patients carry deletions of the long arm of chromosome 11 at 11q22-23 resulted in a significant shorter survival time. 6 ATM is implicated in cell cycle control and DNA repair whose inactivation is considered as a major event in T cell PLL, while loss of heterozygosity of the ATM gene and protein deficiency have been described in adult ALL, as well as in indolent or aggressive lymphomas. 7 However, even if the presence of lymphoid disorders has been demonstrated in AT patients, there is a total absence of myeloid tumors. According to our knowledge, there is no such a case in the literature. We describe a female with typical AT who initially developed a myelodysplastic syndrome (MDS) that progressed to acute myeloid leukemia (AML).
This 19-year-old Greek female was admitted to our Department because of febrile infection of respiratory tract, severe anemia and thrombocytopenia. She suffered from A-T that was diagnosed at the age of 3 years. Her major problems presented in infancy and included progressive cerebellar ataxia, abnormal eye movements and dysarthria. The patient had also developed peripheral neuropathy, thymic hypoplasia, hypogonadism, growth retardation, telangiectasia of the bulbar conjunctiva and diabetes mellitus. During the last 16 years the patient had recurrent sinopulmonary and skin infections due to IgA deficiency and lymphopenia while the administration of ␥-globulins had no effect on the increased tendency to infections. On admission the physical examination revealed pallor, fever (38.2°C), mild hepatomegaly and splenomegaly (2 cm and 3 cm below the costal margin, respectively) and signs of lobal pneumonia. The pulse rate was 92/min and blood pressure was 125/95 mmHg. Her hematological profile was as follows: white blood cell count 5.2 × 10 9 /l (differential count: neutrophils 66%, lymphocytes 18%, monocytes 10%, basophils 1% and blasts 5%), hemoglobin 5.5 g/dl, hematocrit 19.7% and platelet count 72 × 10 9 /l. The peripheral blood smear revealed dysplasia of granulocytes (the Pelger-Huet nuclear abnormality at a proportion of 78% of the mature neutrophils and severe dysgranulopoiesis) and erythrocytes (marked aniso-and poikilocytosis with the presence of elliptocytes, target cells, acanthocytes and dysplastic erythroblasts (12/100 nuclear cells), binucleated or with nuclear fragmentation, and poor hemoglobinization). The reticulocyte count was 1.6% and the erythrocyte sedimentation rate was 62 mm. The biochemical analysis showed increased serum levels of glucose (239 mg/dl), lactate dehydrogenase (720 U/l), ferritin (346.4 ng/ml), CRP (6.8 mg/l) and alpha-fetoprotein (162 ng/ml). The electrophoresis of proteins was within normal limits while the quantitative analysis of immunoglobulins showed decreased levels of IgA (24 mg/dl). The direct Coombs reaction was negative and the level of haptoglobulins was normal. The examination for rheumatic diseases (ANA, anti-DNA, anti-ENA antibodies, RA-test, scl-70, ANCA, APCA, serum C 3 and C 4 levels) was also negative. The thyroid function (serum levels of T 3 , T 4 and TSH) was normal and there was no decrease in serum B 12 and folic acid levels. The chest X-rays revealed pneumonia of the lower right lung lobe with a concomitant small quantity of pleuritic fluid. Ultrasonography showed an ejection fraction of 45%. The detection of cancer serum markers (CEA, CA15.3, CA125, CA19.9, CA 72-4, NSE, CA 27-29, ␤-HCG) and the examination for virus infection (CMV, HSV, VZV, HBV, HCV, Echo, Coxscakie) were negative, as well as the Mantoux reaction. Blood cultures showed the development of streptococcus pneumonia and the administration of penicillin with ciprofloxacin resulted in the disappearance of symptoms and X-ray findings causing the improvement of the patient's physical condition. Because of the dysplastic features of peripheral blood, a bone marrow aspiration and a bone biopsy were performed. The marrow smears showed hyperplasia of the granulocyte series with dysplastic features (hypogranulation, monocytoid appearance of neutrophilic granulocytes and the Pelger-Huet nuclear abnormality) and increased number of type II and III blast cells (13-15%); erythrocytic dysplasia with megaloblastoid changes, nuclear fragmentation and poor hemoglobinization was present, while megakaryocytes with unilobed or bilobed nuclei were also observed. The immunophenotyping of blast cells revealed their myeloid origin (MPO 96%, CD34 64%, CD33 71%, CD13 71%, HLA-DR 60%, CD15 45%) while there were no lymphoid markers on the surface of these cells (CD2, CD3, CD4, CD5, CD7, CD8, CD10, CD19, CD20). The cytogenetic analysis showed an internal deletion of the long arms of chromosome 11 in q22-q23 region [46, XX, del (11) (q22-q23)] (Figure 1 ). The diagnosis of refractory anemia with excess of blasts (RAEB) was set; this myelodysplastic syndrome was of high leukemogenic risk according to the International Prognostic Scoring System. Three months after the initial diagnosis of MDS, patient developed AML, type M 2 according to the FAB classification, with 65% blasts in the bone marrow, without having any change in the karyotypic analysis. She was readmitted to our department, having septicemia from Pseudomonas aeruginosa, and she died 2 days after her admission despite the administration of the combination of piperacillin, tazobactam and amikacin. Unfortunately no material was available after her death for FISH analysis of the area of interest [del 11 (q22;q23)].
The possible role of the ATM gene in cancer predisposition in the general population made it a target for screening in different malignancies. Loss of heterozygosity at the ATM gene and ATM protein deficiency have been described in ALL, B-CLL, T-PLL and NHL, 4 possibly representing major determinants for the prognosis of these disorders. As ATM seems to be required for the normal rearrangement of the T cell receptor alpha/delta locus, it might be reasonable to speculate that this mechanism is associated with the development of lymphoid origin tumors in individuals with ATM mutations. However, despite the demonstrated relationship between ATM and lymphoid malignancies, the presence of myeloid tumors in patients with AT or in carriers of ATM mutation had not been described. The female presented here had a typical AT and developed an MDS of RAEB subtype, with a deletion of the region q22;23 of chromosome 11, which progressed to AML (M 2 ) without any other cytogenetic abnormalities. This was confirmed with a second cytogenetic analysis. Although no translocation involving chromosomes 14 (14q11-TcR␣/␦) or 7 (7q35-TcR␤ and 7p14-TcR␥) was detected in our patient, PCR analysis was performed and confirmed no rearrangement of TcR genes. Also at the genetic level of B-lymphocytes no evidence for clonality was shown by PCR analysis.
Chromosomal translocations involving the 11q23 locus are among the most common in human AML, strongly associated with secondary leukemia and bad prognosis. The vast majority of these translocations involve a single gene, MLL, probably a positive regulator of homeotic gene expression. Recently it has been reported that amplification of the MLL region is also implicated in the development of myeloid leukemic phenotype. 8 Even if we do not have any molecular proof of MLL involvement in our case we may assume that the ATM gene
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Karyotype with del(11) (q22;q23). mutation could create environmental conditions similar to those in patients exposed to radiation or chemotherapy that led to secondary leukemia with possible involvement of MLL locus. Clinical presentation, FISH and molecular studies of such cases will help us to understand the function and possible interactions of the ATM gene with other genes and reveal mechanisms that lead to hematological malignancies not only of lymphoid, but of myeloid origin too.
